 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, April 1, 2002, 22(7):2835-2842
Effects of Reversible Inactivation of the Neonatal Ventral Hippocampus on Behavior in the Adult Rat
Barbara K. Lipska, Nader D. Halim, Pavan N. Segal, and Daniel R. Weinberger Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892-1385
Rats with neonatal excitotoxic damage of the ventral hippocampus display in adulthood a variety of abnormalities reminiscent of schizophrenia and are used as an animal model of this disorder. In the present study, we hypothesized that transient inactivation of ventral hippocampal activity during a critical developmental period may be sufficient to disrupt normal maturation of relevant brain systems and produce similar lasting behavioral changes. We infused tetrodotoxin (TTX) or artificial CSF into the ventral hippocampus on postnatal day 7 (P7) and assessed behavioral changes in response to stress, amphetamine, and (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine maleate in juvenile (P35) and young adult (P56) rats. In adulthood, rats infused neonatally with TTX displayed motor hyperactivity after pharmacological stimulation and after stress compared with sham controls. Analogous TTX infusions in adult animals did not alter these behaviors later in life. These data suggest that transient loss of ventral hippocampal function during a critical time in maturation of intracortical connections permanently changes the development of neural circuits mediating certain dopamine- and NMDA-related behaviors. These results represent a potential new model of aspects of schizophrenia without involving a gross anatomic lesion.
Key words: tetrodotoxin; animal model; schizophrenia; amphetamine; MK-801; locomotion
Copyright © 2002 Society for Neuroscience 0270-6474/02/2272835-08$05.00/0
This article has been cited by other articles:
W. Li, Y. Zhou, J. D. Jentsch, R. A. M. Brown, X. Tian, D. Ehninger, W. Hennah, L. Peltonen, J. Lonnqvist, M. O. Huttunen, et al.
Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice
PNAS, November 13, 2007; 104(46): 18280 - 18285.
[Abstract] [Full Text] [PDF]
T. Hershey, D. C. Perantie, S. L. Warren, E. C. Zimmerman, M. Sadler, and N. H. White
Frequency and Timing of Severe Hypoglycemia Affects Spatial Memory in Children With Type 1 Diabetes
Diabetes Care, October 1, 2005; 28(10): 2372 - 2377.
[Abstract] [Full Text] [PDF]
L. Costantin, Y. Bozzi, C. Richichi, A. Viegi, F. Antonucci, M. Funicello, M. Gobbi, T. Mennini, O. Rossetto, C. Montecucco, et al.
Antiepileptic Effects of Botulinum Neurotoxin E
J. Neurosci., February 23, 2005; 25(8): 1943 - 1951.
[Abstract] [Full Text] [PDF]
R E Lubow
Construct Validity of the Animal Latent Inhibition Model of Selective Attention Deficits in Schizophrenia
Schizophr Bull, January 1, 2005; 31(1): 139 - 153.
[Abstract] [Full Text] [PDF]
L. J. Siever and K. L. Davis
The Pathophysiology of Schizophrenia Disorders: Perspectives From the Spectrum
Am J Psychiatry, March 1, 2004; 161(3): 398 - 413.
[Abstract] [Full Text] [PDF]
P. R. Szeszko, E. Goldberg, H. Gunduz-Bruce, M. Ashtari, D. Robinson, A. K. Malhotra, T. Lencz, J. Bates, D. T. Crandall, J. M. Kane, et al.
Smaller Anterior Hippocampal Formation Volume in Antipsychotic-Naive Patients With First-Episode Schizophrenia
Am J Psychiatry, December 1, 2003; 160(12): 2190 - 2197.
[Abstract] [Full Text] [PDF]
Y. Goto and P. O'Donnell
Delayed Mesolimbic System Alteration in a Developmental Animal Model of Schizophrenia
J. Neurosci., October 15, 2002; 22(20): 9070 - 9077.
[Abstract] [Full Text] [PDF]
P. O'Donnell, B. L. Lewis, D. R. Weinberger, and B. K. Lipska
Neonatal Hippocampal Damage Alters Electrophysiological Properties of Prefrontal Cortical Neurons in Adult Rats
Cereb Cortex, September 1, 2002; 12(9): 975 - 982.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|